Market Chatter: TDS Pharm Shares Surge Over 174% on KOSDAQ Debut on Aug. 21

MT Newswires Live08-22

Shares of South Korean pharmaceutical firm TDS Pharm (KOSDAQ:464280) plunged nearly 19% on Thursday after it soared on its debut on the secondary market KOSDAQ on Wednesday.

As of Wednesday morning, stocks were trading at 35,650 won, a 174.23% jump from the offering price of 13,000 won, Pulse News reported Wednesday.

The competition ratio for the bookbuilding session was 1,331.2 to 1, with the offering price exceeding the target range of 9,500 won to 10,700 won. During the public subscription period, the competition ratio was 1,608.17 to 1, it said.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment